As the first line of care and trusted healthcare providers in their communities, primary care doctors play an essential role in recognising cardiovascular risk and guiding patients through their care journey. CVS² provided a space to strengthen this connection and share the latest approaches in cardiovascular care.

 

Our Heart Team covered key topics including LDL-C management, semaglutide, pulmonary embolism and renal denervation, before exploring the new era of heart rhythm therapy with pulsed field ablation and next-gen implantable cardioverter defibrillators.

 

To all the participants who joined us and shared your experiences, thank you! Your participation made the discussions richer and the afternoon truly worthwhile. We hope you left with practical insights to bring back to your patients.

 

Our sincere appreciation also goes to Boston Scientific, Getz Healthcare, Medtronic, Menarini, Novartis and Novo Nordisk for supporting CVS² Symposium 2026.